Related Experiment Video
Updated: Aug 7, 2026

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
Published on: June 11, 2011
Mucosal and invasive fungal infections in HIV/AIDS
C A Hage1, M Goldman, L J Wheat
1Indiana University School of Medicine, Indianapolis Department of Veterans Affairs Hospital, USA. lwheat@iupui.edu
Abstract:
Advances in the management of fungal infections in AIDS justify this review. First, their incidence has fallen with the introduction of potent antiretroviral therapy. Now, most cases occur in patients with advanced HIV disease who have failed multiple antiretroviral regimens, are nonadherent to therapy, or treatment na ve. Immune reconstitution has reduced the incidence of these infections and permitted discontinuation of maintenance therapy. However, the immune response to antiretroviral therapy has resulted in paradoxical worsening in some cases, "so-called immune reconstitution inflammatory syndromes". Finally, new antifungal agents expand our treatment choices. This review updates management of fungal infections in AIDS.
Insights
Management of fungal infections in acquired immunodeficiency syndrome (AIDS) has improved due to potent antiretroviral therapy (ART). While ART reduces incidence, immune reconstitution inflammatory syndromes and new antifungal agents require updated treatment strategies for HIV patients.
Area of Science:
- Infectious Diseases
- Immunology
- Pharmacology
Background:
- Fungal infections were historically common in patients with acquired immunodeficiency syndrome (AIDS).
- The advent of potent antiretroviral therapy (ART) has significantly reduced the incidence of these infections.
- Current cases often involve patients with advanced HIV disease, treatment failure, or those treatment-naïve.
Purpose of the Study:
- To provide an updated review on the management of fungal infections in patients with AIDS.
- To discuss the impact of ART on the incidence and presentation of fungal infections.
- To highlight new therapeutic options and challenges in managing these infections.
Main Methods:
- This review synthesizes current literature on fungal infections in AIDS.
- It examines the influence of antiretroviral therapy on disease incidence and immune reconstitution.
- The review considers the emergence of immune reconstitution inflammatory syndromes (IRIS) and new antifungal agents.
Main Results:
- Antiretroviral therapy has led to a decreased incidence of fungal infections in AIDS patients.
- Immune reconstitution can reduce infection rates and allow for discontinuation of maintenance therapy.
- Paradoxical worsening of fungal infections, known as IRIS, can occur due to immune reconstitution.
- New antifungal agents offer expanded treatment choices.
Conclusions:
- The management of fungal infections in AIDS has evolved significantly with ART.
- Updated strategies are necessary to address the changing epidemiology and challenges like IRIS.
- Continued research and clinical vigilance are crucial for optimal patient outcomes.
More Related Videos
07:21Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019
07:42An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Sexually Transmitted Infections
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Fungal Phylum Microsporidia
Cryptococcal Meningitis
Candidiasis